Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
25%
Ph early_phase_1
1
13%
Ph phase_1
5
63%

Phase Distribution

6

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
5(62.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Other(2)

Detailed Status

Completed4
unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (12.5%)
Phase 15 (62.5%)
N/A2 (25.0%)

Trials by Status

recruiting113%
unknown225%
not_yet_recruiting113%
completed450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8